DIGGER0126 Oct 2020 14:34
Hi
I also picked up your point regarding the primary end point from the rns released regarding trial.
It seemed to me that the FDA have for some reason made the sucsess of the trial more achievable for vrp...... i also think the delisting from the aim is in preperation for forthcoming news regarding covid trial and ongoing copd trial .
AIM is regarded by investors as a form of gambling and to be listed on Aim going into the future for verona would be a hinderance .
Aim has served its purpose but the reality is its time to move on and target usa market without the baggage of being an AIM listed company .
Imho. Of course